SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001529224-22-000001
Filing Date
2022-09-20
Accepted
2022-09-20 11:50:18
Documents
1
Effectiveness Date
2022-09-20
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9103
  Complete submission text file 0001529224-22-000001.txt   10273
Mailing Address 100 CAPITOLA DRIVE SUITE 275 DURHAM NC 27713
Business Address 100 CAPITOLA DRIVE SUITE 275 DURHAM NC 27713 (919) 973-6544
GeneCentric Therapeutics, Inc. (Filer) CIK: 0001529224 (see all company filings)

IRS No.: 452540158 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-459294 | Film No.: 221252641